Literature DB >> 35747083

COVID-19: the heart and other issues.

Cormac T O'Connor1, David Mulcahy2.   

Abstract

From the time that the first cases were reported from Wuhan, China on the 31st December 2019,1 our knowledge of the clinical and virological associations of the novel coronavirus (COVID-19) has been evolving at a rapid pace. On 18th May 2020, COVID-19 had caused over 4.82 million cases worldwide and resulted in 316,959 deaths.2 Whilst the primary focus of management for patients with COVID-19 remains close monitoring of respiratory function, there have been high levels of cardiac dysfunction in emerging cross-sectional and observational analyses, suggesting the need for heightened awareness in patients who may require cardiac input as part of a multidisciplinary approach. We review the current data on the association of COVID-19 and the heart.
Copyright © 2020 Medinews (Cardiology) Limited.

Entities:  

Keywords:  ACE2; COVID-19; Kawasaki disease; azithromycin; biomarkers; heart disease; hydroxychloroquine; remdesivir

Year:  2020        PMID: 35747083      PMCID: PMC9205237          DOI: 10.5837/bjc.2020.018

Source DB:  PubMed          Journal:  Br J Cardiol        ISSN: 0969-6113


  43 in total

Review 1.  Non-specific effects of vaccines: plausible and potentially important, but implications uncertain.

Authors:  Andrew J Pollard; Adam Finn; Nigel Curtis
Journal:  Arch Dis Child       Date:  2017-05-13       Impact factor: 3.791

Review 2.  The role of ACE2 in cardiovascular physiology.

Authors:  Gavin Y Oudit; Michael A Crackower; Peter H Backx; Josef M Penninger
Journal:  Trends Cardiovasc Med       Date:  2003-04       Impact factor: 6.677

3.  The BCG World Atlas: a database of global BCG vaccination policies and practices.

Authors:  Alice Zwerling; Marcel A Behr; Aman Verma; Timothy F Brewer; Dick Menzies; Madhukar Pai
Journal:  PLoS Med       Date:  2011-03-22       Impact factor: 11.069

4.  Compassionate Use of Remdesivir for Patients with Severe Covid-19.

Authors:  Jonathan Grein; Norio Ohmagari; Daniel Shin; George Diaz; Erika Asperges; Antonella Castagna; Torsten Feldt; Gary Green; Margaret L Green; François-Xavier Lescure; Emanuele Nicastri; Rentaro Oda; Kikuo Yo; Eugenia Quiros-Roldan; Alex Studemeister; John Redinski; Seema Ahmed; Jorge Bernett; Daniel Chelliah; Danny Chen; Shingo Chihara; Stuart H Cohen; Jennifer Cunningham; Antonella D'Arminio Monforte; Saad Ismail; Hideaki Kato; Giuseppe Lapadula; Erwan L'Her; Toshitaka Maeno; Sumit Majumder; Marco Massari; Marta Mora-Rillo; Yoshikazu Mutoh; Duc Nguyen; Ewa Verweij; Alexander Zoufaly; Anu O Osinusi; Adam DeZure; Yang Zhao; Lijie Zhong; Anand Chokkalingam; Emon Elboudwarej; Laura Telep; Leighann Timbs; Ilana Henne; Scott Sellers; Huyen Cao; Susanna K Tan; Lucinda Winterbourne; Polly Desai; Robertino Mera; Anuj Gaggar; Robert P Myers; Diana M Brainard; Richard Childs; Timothy Flanigan
Journal:  N Engl J Med       Date:  2020-04-10       Impact factor: 91.245

5.  Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Yeming Wang; Dingyu Zhang; Guanhua Du; Ronghui Du; Jianping Zhao; Yang Jin; Shouzhi Fu; Ling Gao; Zhenshun Cheng; Qiaofa Lu; Yi Hu; Guangwei Luo; Ke Wang; Yang Lu; Huadong Li; Shuzhen Wang; Shunan Ruan; Chengqing Yang; Chunlin Mei; Yi Wang; Dan Ding; Feng Wu; Xin Tang; Xianzhi Ye; Yingchun Ye; Bing Liu; Jie Yang; Wen Yin; Aili Wang; Guohui Fan; Fei Zhou; Zhibo Liu; Xiaoying Gu; Jiuyang Xu; Lianhan Shang; Yi Zhang; Lianjun Cao; Tingting Guo; Yan Wan; Hong Qin; Yushen Jiang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Bin Cao; Chen Wang
Journal:  Lancet       Date:  2020-04-29       Impact factor: 79.321

6.  Hyperinflammatory shock in children during COVID-19 pandemic.

Authors:  Shelley Riphagen; Xabier Gomez; Carmen Gonzalez-Martinez; Nick Wilkinson; Paraskevi Theocharis
Journal:  Lancet       Date:  2020-05-07       Impact factor: 79.321

7.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.

Authors:  Keiji Kuba; Yumiko Imai; Shuan Rao; Hong Gao; Feng Guo; Bin Guan; Yi Huan; Peng Yang; Yanli Zhang; Wei Deng; Linlin Bao; Binlin Zhang; Guang Liu; Zhong Wang; Mark Chappell; Yanxin Liu; Dexian Zheng; Andreas Leibbrandt; Teiji Wada; Arthur S Slutsky; Depei Liu; Chuan Qin; Chengyu Jiang; Josef M Penninger
Journal:  Nat Med       Date:  2005-07-10       Impact factor: 53.440

8.  Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.

Authors:  Elisa Nemes; Hennie Geldenhuys; Virginie Rozot; Kathryn T Rutkowski; Frances Ratangee; Nicole Bilek; Simbarashe Mabwe; Lebohang Makhethe; Mzwandile Erasmus; Asma Toefy; Humphrey Mulenga; Willem A Hanekom; Steven G Self; Linda-Gail Bekker; Robert Ryall; Sanjay Gurunathan; Carlos A DiazGranados; Peter Andersen; Ingrid Kromann; Thomas Evans; Ruth D Ellis; Bernard Landry; David A Hokey; Robert Hopkins; Ann M Ginsberg; Thomas J Scriba; Mark Hatherill
Journal:  N Engl J Med       Date:  2018-07-12       Impact factor: 91.245

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak.

Authors:  Tao Zhang; Qunfu Wu; Zhigang Zhang
Journal:  Curr Biol       Date:  2020-03-19       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.